Ophthalmology
Adverse effects and Safety in Glaucoma Patients – Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD) – A Delphi Consensus Statement.
26 May, 2022 | 10:14h | UTC
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for impaired visual acuity in older adults.
25 May, 2022 | 11:44h | UTCEditorials:
Visual Acuity Screening in Older Adults – JAMA Ophthalmology
Screening for Impaired Visual Acuity in Older Adults – JAMA
Evidence Report: Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Impaired Visual Acuity in Older Adults – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults – JAMA
USPSTF Recommendation Statement: The current evidence is insufficient to make a recommendation about screening for primary open-angle glaucoma in adults.
25 May, 2022 | 11:46h | UTCEditorials:
Identifying Glaucoma in Primary Care Offices – JAMA Ophthalmology
Evidence Report: Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA
Patient Page: Screening for Primary Open-Angle Glaucoma – JAMA
Author Interview: USPSTF Recommendations: Screening for Primary Open-Angle Glaucoma and Screening for Impaired Visual Acuity in Older Adults
M-A: The global prevalence of amblyopia in children.
24 May, 2022 | 07:29h | UTC
Network meta-analysis of different intravenous glucocorticoid regimes for the treatment of Graves’ orbitopathy.
20 May, 2022 | 10:34h | UTC
Artificial intelligence for screening of multiple retinal and optic nerve diseases.
9 May, 2022 | 01:18h | UTC
Commentary on Twitter
This diagnostic study developed and prospectively validated a #DeepLearning algorithm to recognize multiple retinal diseases, with better accuracy vs retinal specialists, and may help to overcome the lack of ophthalmologists in underdeveloped areas. https://t.co/9fvwOTVV8N
— JAMA Network Open (@JAMANetworkOpen) May 3, 2022
Advancing the Sustainable Development Goals through improving eye health: a scoping review.
5 May, 2022 | 10:01h | UTC
Current Guidelines on management of amaurosis fugax and transient ischemic attacks.
5 May, 2022 | 09:50h | UTC
Systematic Review: Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.
26 Apr, 2022 | 07:52h | UTC
Retinal age gap as a predictive biomarker of future risk of Parkinson’s disease.
21 Apr, 2022 | 09:54h | UTCRetinal age gap as a predictive biomarker of future risk of Parkinson’s disease – Age and Ageing
Related: Retinal age gap as a predictive biomarker for mortality risk – British Journal of Ophthalmology (link to abstract – $ for full-text)
Cohort Study: Changes in the incidence of retinal vascular occlusions after COVID-19 diagnosis.
18 Apr, 2022 | 10:34h | UTCCommentaries:
COVID-19 Diagnosis and Incidence of Retinal Thromboembolism – JAMA Ophthalmology
Threatening Eye Condition Rare After COVID Infection – HealthDay
Cohort Study: Use of Phosphodiesterase 5 Inhibitors linked to increased risk of ocular adverse events.
8 Apr, 2022 | 11:04h | UTCRisk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (free for a limited period)
News Release: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia
Commentaries:
Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (free for a limited period)
Could Viagra, Cialis Raise Men’s Odds for Eye Trouble? – HealthDay
Study Commentary | Advanced glaucoma: surgery lowers pressure in the eye more effectively than eye drops.
8 Apr, 2022 | 10:06h | UTC
Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk.
7 Apr, 2022 | 08:18h | UTC
Expert Consensus: Stepwise diagnostic approach for patients with uveitis.
7 Apr, 2022 | 07:53h | UTC
Randomized, comparative effectiveness study: 3 at-home visual acuity tests validated through comparison with in-office visual acuity measurements, supporting their potential use in teleophthalmology care.
4 Apr, 2022 | 01:17h | UTCValidation of Home Visual Acuity Tests for Telehealth in the COVID-19 Era – JAMA Ophthalmology (free for a limited period)
Commentaries:
Valid but Undervalued – JAMA Ophthalmology (free for a limited period)
At-Home Visual Acuity Tests Valid Versus In-Office Testing – HealthDay
M-A: Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes.
4 Apr, 2022 | 00:42h | UTCGlobal Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis – JAMA Ophthalmology (free for a limited period)
Invited Commentary: Diabetic Retinopathy in Pregnancy – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
In this study, higher #diabeticretinopathy (DR) prevalences were found in pregnant women with pre-existing #diabetes compared w non-pregnant women. Women with T2D compared w T1D were not noted to have a different risk of DR progression during pregnancy. https://t.co/lfTi9kIBTj
— JAMAOphthalmology (@JAMAOphth) April 1, 2022
RCT: Spectacle lenses with aspherical lenslets for myopia control vs. single-vision spectacle lenses.
4 Apr, 2022 | 00:41h | UTCInvited Commentary: Clinical Relevance of Myopia Control With Specialized Spectacles – JAMA Ophthalmology (free for a limited period)
Commentary on Twitter
Study found that a higher asphericity of lenslets may be associated with more effective myopia control in children with #myopia. https://t.co/lEOIXj9qYG
— JAMAOphthalmology (@JAMAOphth) March 31, 2022
Systematic Review: The economics of vision impairment and its leading causes.
31 Mar, 2022 | 07:53h | UTCThe economics of vision impairment and its leading causes: A systematic review – EClinicalMedicine
Real-time diabetic retinopathy screening by deep learning in a multisite national screening program: a prospective interventional cohort study.
29 Mar, 2022 | 08:17h | UTCInvited Commentary: Artificial intelligence deployment in diabetic retinopathy: the last step of the translation continuum – The Lancet Digital Health
Study suggests an association of strabismus with mood disorders, schizophrenia, and anxiety disorders among children.
24 Mar, 2022 | 08:14h | UTCAssociation of Strabismus With Mood Disorders, Schizophrenia, and Anxiety Disorders Among Children – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Moderate Associations ID’d for Strabismus, Mental Health Disorders – HealthDay
Commentary on Twitter
A study evaluating over 10 million insurance claims, found an association between having a diagnosis of strabismus and anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder, but not substance-use disorder. https://t.co/MkyF26QJ3U
— JAMAOphthalmology (@JAMAOphth) March 10, 2022
Retinal vein occlusion (RVO) guideline: executive summary.
23 Mar, 2022 | 10:13h | UTCRetinal vein occlusion (RVO) guideline: executive summary – Eye
The incidence of ocular complications in candidemic patients and implications for the practice of routine eye exams.
23 Mar, 2022 | 09:50h | UTC
Study shows low risk of acute myocardial infarction after ophthalmologic procedures, confirming previous knowledge that preoperative evaluation may be unnecessary for most patients.
22 Mar, 2022 | 08:47h | UTCRisk for Acute Myocardial Infarction After Ophthalmologic Procedures – Annals of Internal Medicine (link to abstract – $ for full-text)
Summary for patients: Summary for Patients: Risk for Heart Attack After Eye Procedures
Editorial: Preoperative Evaluation Can Delay Ophthalmologic Surgery Without Improving Outcomes ($)
Commentary: Ophthalmologic Procedures Not Tied to Increased AMI Risk – HealthDay
Related:
Systematic Review: Routine Preoperative Medical Testing for Cataract Surgery
Commentary on Twitter
Ever had to do a pre-operative risk stratification prior to outpatient optho procedure? Have data to back up your rec? Now you have more ?https://t.co/2wD7O6byuX
Inpatient #registry study from ??&??
>40y. 806 patients.
No association with ⬆️#AMI risk. #CardioTwitter
— Amitabh C. Pandey (@AmitabhCPandey) March 21, 2022
RCT: Safety and efficacy of AGN-190584 in individuals with presbyopia.
22 Mar, 2022 | 08:20h | UTC
Commentary on Twitter
A new proprietary formulation of pilocarpine developed to treat presbyopia met its primary endpoint in the GEMINI phase 3 clinical trial, safely and effectively improving distance-corrected mesopic near vision for hours after eye drop instillation. https://t.co/WG5DZ6XQxZ pic.twitter.com/YXnW387R7i
— JAMAOphthalmology (@JAMAOphth) March 4, 2022